Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders
- PMID: 10432494
- DOI: 10.1016/S0893-133X(99)00036-6
Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders
Abstract
The therapeutic effectiveness of antidepressant drugs in major depression was discovered by pure serendipity. It took over 20 years before the neurobiological modifications that could mediate the antidepressive response were put into evidence. Indeed, whereas the immediate biochemical effects of these drugs had been well documented, their antidepressant action generally does not become apparent before 2 to 3 weeks of treatment. The different classes of antidepressant treatments were subsequently shown to enhance serotonin neurotransmission albeit via different pre- and postsynaptic mechanisms. Clinical trials based on this hypothesis led to the development of treatment strategies producing greater efficacy and more rapid onset of antidepressant action; that, is lithium addition and pindolol combination, respectively. It is expected that the better understanding recently obtained of the mechanism of action of certain antidepressant drugs in obsessive-compulsive and panic disorders will also lead to more effective treatment strategies for those disorders.
Similar articles
-
Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.Biol Psychiatry. 1998 Sep 1;44(5):313-23. doi: 10.1016/s0006-3223(98)00114-0. Biol Psychiatry. 1998. PMID: 9755353 Review.
-
Serotonin selectivity for obsessive compulsive and panic disorders.J Psychiatry Neurosci. 1991 Jul;16(2 Suppl 1):30-5. J Psychiatry Neurosci. 1991. PMID: 1931935 Free PMC article. Review. No abstract available.
-
Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.J Clin Psychiatry. 1985 Oct;46(10 Pt 2):6-24. J Clin Psychiatry. 1985. PMID: 3900056 Review.
-
How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.J Clin Psychiatry. 1996;57 Suppl 4:9-13. J Clin Psychiatry. 1996. PMID: 8636065
-
Therapeutic potential of serotonin antagonists in depressive disorders.Expert Opin Investig Drugs. 2002 Apr;11(4):457-67. doi: 10.1517/13543784.11.4.457. Expert Opin Investig Drugs. 2002. PMID: 11922855 Review.
Cited by
-
In vivo measurements of brain trapping of C-labelled alpha-methyl-L-tryptophan during acute changes in mood states.J Psychiatry Neurosci. 2007 Nov;32(6):430-4. J Psychiatry Neurosci. 2007. PMID: 18043767 Free PMC article.
-
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response.J Psychiatry Neurosci. 2004 May;29(3):208-18. J Psychiatry Neurosci. 2004. PMID: 15173897 Free PMC article.
-
Acute 5-HT reuptake blockade potentiates human amygdala reactivity.Neuropsychopharmacology. 2008 Dec;33(13):3221-5. doi: 10.1038/npp.2008.52. Epub 2008 May 7. Neuropsychopharmacology. 2008. PMID: 18463627 Free PMC article. Clinical Trial.
-
Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.PET Clin. 2009 Jan;4(1):101-28. doi: 10.1016/j.cpet.2009.05.006. PET Clin. 2009. PMID: 20216936 Free PMC article.
-
Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adults.Psychiatry Res Neuroimaging. 2016 Sep 30;255:81-6. doi: 10.1016/j.pscychresns.2016.08.002. Epub 2016 Aug 8. Psychiatry Res Neuroimaging. 2016. PMID: 27567324 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical